Rapport Therapeutics, Inc.
RAPP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002012593
In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
Superinvestors holding RAPP, Q2 2026
No superinvestor reported holding RAPP in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RAPP each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q2 2024
1 superinvestor holding at quarter end